Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1983 Nov;139(5):688–695.

Hypoglycemia: A Pitfall of Insulin Therapy

PMCID: PMC1010967  PMID: 6362204

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Associate Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Chairman of the Department of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bale R. N. Brain damage in diabetes mellitus. Br J Psychiatry. 1973 Mar;122(568):337–341. doi: 10.1192/bjp.122.3.337. [DOI] [PubMed] [Google Scholar]
  2. Basdevant A., Costagliola D., Lanöe J. L., Goldgewicht C., Triomphe A., Metz F., Denys H., Eschwege E., Fardeau M., Tchobroutsky G. The risk of diabetic control: a comparison of hospital versus general practice supervision. Diabetologia. 1982 May;22(5):309–314. doi: 10.1007/BF00253572. [DOI] [PubMed] [Google Scholar]
  3. Boden G., Reichard G. A., Jr, Hoeldtke R. D., Rezvani I., Owen O. E. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med. 1981 Nov 12;305(20):1200–1205. doi: 10.1056/NEJM198111123052007. [DOI] [PubMed] [Google Scholar]
  4. Bolli G., de Feo P., Compagnucci P., Cartechini M. G., Angeletti G., Santeusanio F., Brunetti P., Gerich J. E. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes. 1983 Feb;32(2):134–141. doi: 10.2337/diab.32.2.134. [DOI] [PubMed] [Google Scholar]
  5. Burditt A. G., Caird F. I., Draper G. J. The natural history of diabetic retinopathy. Q J Med. 1968 Apr;37(146):303–317. [PubMed] [Google Scholar]
  6. CHASE P. H., TRACHTMAN B., ZAROWITZ H. Hypoglycemic cardiac arrhythmia in early diabetes mellitus. N Y State J Med. 1962 Nov 15;62:3647–3652. [PubMed] [Google Scholar]
  7. Cahill G. F., Jr, Etzwiler L. D., Freinkel N. Editorial: "Control" and diabetes. N Engl J Med. 1976 Apr 29;294(18):1004–1005. doi: 10.1056/NEJM197604292941811. [DOI] [PubMed] [Google Scholar]
  8. Cryer P. E., Gerich J. E. Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrine. Diabetes Care. 1983 Jan-Feb;6(1):95–99. doi: 10.2337/diacare.6.1.95. [DOI] [PubMed] [Google Scholar]
  9. Cryer P. E. Glucose counterregulation in man. Diabetes. 1981 Mar;30(3):261–264. doi: 10.2337/diab.30.3.261. [DOI] [PubMed] [Google Scholar]
  10. Darlow B. A., Abbott G. D., Scandrett M. S., Steer B. Early morning urinary cortisol/creatinine ratios, an unreliable test for nocturnal hypoglycaemia in juvenile diabetics. Lancet. 1980 Aug 2;2(8188):266–267. doi: 10.1016/s0140-6736(80)90158-0. [DOI] [PubMed] [Google Scholar]
  11. Deckert T., Poulsen J. E., Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978 Jun;14(6):363–370. doi: 10.1007/BF01228130. [DOI] [PubMed] [Google Scholar]
  12. EGELI E. S., BERKMEN R. Action of hypoglycemia on coronary insufficiency and mechanism of ECG alterations. Am Heart J. 1960 Apr;59:527–540. doi: 10.1016/0002-8703(60)90456-7. [DOI] [PubMed] [Google Scholar]
  13. Eeg-Olofsson O. Hypoglycemia and neurological disturbances in children with diabetes mellitus. Acta Paediatr Scand Suppl. 1977;(270):91–96. doi: 10.1111/j.1651-2227.1977.tb15127.x. [DOI] [PubMed] [Google Scholar]
  14. Felig P., Bergman M. Intensive ambulatory treatment of insulin-dependent diabetes. Ann Intern Med. 1982 Aug;97(2):225–230. doi: 10.7326/0003-4819-97-2-225. [DOI] [PubMed] [Google Scholar]
  15. Frier B. M., Matthews D. M., Steel J. M., Duncan L. J. Driving and insulin-dependent diabetes. Lancet. 1980 Jun 7;1(8180):1232–1234. doi: 10.1016/s0140-6736(80)91690-6. [DOI] [PubMed] [Google Scholar]
  16. Gale E. A., Tattersall R. B. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet. 1979 May 19;1(8125):1049–1052. doi: 10.1016/s0140-6736(79)92950-7. [DOI] [PubMed] [Google Scholar]
  17. Gale E. A., Walford S., Tattersall R. B. Nocturnal hypoglycaemia and haemoglobin A1. Lancet. 1979 Dec 8;2(8154):1240–1241. doi: 10.1016/s0140-6736(79)92356-0. [DOI] [PubMed] [Google Scholar]
  18. Gale E. Hypoglycaemia. Clin Endocrinol Metab. 1980 Nov;9(3):461–475. [PubMed] [Google Scholar]
  19. Gerich J. E., Langlois M., Noacco C., Karam J. H., Forsham P. H. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973 Oct 12;182(4108):171–173. doi: 10.1126/science.182.4108.171. [DOI] [PubMed] [Google Scholar]
  20. Goldstein D. E., England J. D., Hess R., Rawlings S. S., Walker B. A prospective study of symptomatic hypoglycemia in young diabetic patients. Diabetes Care. 1981 Nov-Dec;4(6):601–605. doi: 10.2337/diacare.4.6.601. [DOI] [PubMed] [Google Scholar]
  21. Haumont D., Dorchy H., Pelc S. EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) 1979 Dec;18(12):750–753. doi: 10.1177/000992287901801205. [DOI] [PubMed] [Google Scholar]
  22. Hilsted J., Madsbad S., Krarup T., Sestoft L., Christensen N. J., Tronier B., Galbo H. Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes. 1981 Aug;30(8):626–633. doi: 10.2337/diab.30.8.626. [DOI] [PubMed] [Google Scholar]
  23. Hoeldtke R. D., Boden G., Shuman C. R., Owen O. E. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med. 1982 Apr;96(4):459–462. doi: 10.7326/0003-4819-96-4-459. [DOI] [PubMed] [Google Scholar]
  24. Holman R. R., Dornan T. L., Mayon-White V., Howard-Williams J., Orde-Peckar C., Jenkins L., Steemson J., Rolfe R., Smith B., Barbour D. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. Lancet. 1983 Jan 29;1(8318):204–208. doi: 10.1016/s0140-6736(83)92586-2. [DOI] [PubMed] [Google Scholar]
  25. Kussman M. J., Goldstein H., Gleason R. E. The clinical course of diabetic nephropathy. JAMA. 1976 Oct 18;236(16):1861–1863. [PubMed] [Google Scholar]
  26. Lauritzen T., Frost-Larsen K., Larsen H. W., Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983 Jan 29;1(8318):200–204. doi: 10.1016/s0140-6736(83)92585-0. [DOI] [PubMed] [Google Scholar]
  27. Moore R. A., Smith R. F., Asplin C. M. Simple test for nocturnal hypoglycaemia in diabetic patients. Lancet. 1979 Feb 24;1(8113):409–410. doi: 10.1016/s0140-6736(79)90884-5. [DOI] [PubMed] [Google Scholar]
  28. Nabarro J. D., Mustaffa B. E., Morris D. V., Walport M. J., Kurtz A. B. Insulin deficient diabetes. Contrasts with other endocrine deficiencies. Diabetologia. 1979 Jan;16(1):5–12. doi: 10.1007/BF00423143. [DOI] [PubMed] [Google Scholar]
  29. Paz-Guevara A. T., Hsu T. H., White P. Juvenile diabetes mellitus after forty years. Diabetes. 1975 Jun;24(6):559–565. doi: 10.2337/diab.24.6.559. [DOI] [PubMed] [Google Scholar]
  30. Pettitt D. J., Knowler W. C., Lisse J. R., Bennett P. H. Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet. 1980 Nov 15;2(8203):1050–1052. doi: 10.1016/s0140-6736(80)92274-6. [DOI] [PubMed] [Google Scholar]
  31. Polonsky K., Bergenstal R., Pons G., Schneider M., Jaspan J., Rubenstein A. Relation of counterregulatory responses to hypoglycemia in type I diabetics. N Engl J Med. 1982 Oct 28;307(18):1106–1112. doi: 10.1056/NEJM198210283071802. [DOI] [PubMed] [Google Scholar]
  32. Popp D. A., Shah S. D., Cryer P. E. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest. 1982 Feb;69(2):315–326. doi: 10.1172/JCI110455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Puklin J. E., Tamborlane W. V., Felig P., Genel M., Sherwin R. S. Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy. Ophthalmology. 1982 Jul;89(7):735–747. doi: 10.1016/s0161-6420(82)34730-2. [DOI] [PubMed] [Google Scholar]
  34. Rosenbloom A. L., Giordano B. P. Chronic overtreatment with insulin in children and adolescents. Am J Dis Child. 1977 Aug;131(8):881–885. doi: 10.1001/archpedi.1977.02120210059012. [DOI] [PubMed] [Google Scholar]
  35. SUSSMAN K. E., CROUT J. R., MARBLE A. Failure of warning in insulin-induced hypoglycemic reactions. Diabetes. 1963 Jan-Feb;12:38–45. doi: 10.2337/diab.12.1.38. [DOI] [PubMed] [Google Scholar]
  36. Saccà L., Sherwin R., Hendler R., Felig P. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J Clin Invest. 1979 May;63(5):849–857. doi: 10.1172/JCI109384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Santeusanio F., Bolli G., Massi-Benedetti M., De Feo P., Angeletti G., Compagnucci P., Calabrese G., Brunetti P. Counterregulatory hormones during moderate, insulin-induced, blood glucose decrements in man. J Clin Endocrinol Metab. 1981 Mar;52(3):477–482. doi: 10.1210/jcem-52-3-477. [DOI] [PubMed] [Google Scholar]
  38. Santiago J. V., Clarke W. L., Shah S. D., Cryer P. E. Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab. 1980 Oct;51(4):877–883. doi: 10.1210/jcem-51-4-877. [DOI] [PubMed] [Google Scholar]
  39. Sayegh H. A., Jarrett R. J. Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey. Lancet. 1979 Sep 1;2(8140):431–433. doi: 10.1016/s0140-6736(79)91489-2. [DOI] [PubMed] [Google Scholar]
  40. Scott R. S., Scandrett M. S. Nocturnal cortisol release during hypoglycemia in diabetes. Diabetes Care. 1981 Sep-Oct;4(5):514–518. doi: 10.2337/diacare.4.5.514. [DOI] [PubMed] [Google Scholar]
  41. Seaworth J. F., Seaworth B. J., Jordan R. M. Urine cortisol/creatinine ratio in controlled insulin-induced hypoglycemia. Diabetes Care. 1981 Sep-Oct;4(5):559–560. doi: 10.2337/diacare.4.5.559. [DOI] [PubMed] [Google Scholar]
  42. Seltzer H. S. Drug-induced hypoglycemia. A review based on 473 cases. Diabetes. 1972 Sep;21(9):955–966. doi: 10.2337/diab.21.9.955. [DOI] [PubMed] [Google Scholar]
  43. Silas J. H., Grant D. S., Maddocks J. L. Transient hemiparetic attacks due to unrecognised nocturnal hypoglycaemia. Br Med J (Clin Res Ed) 1981 Jan 10;282(6258):132–133. doi: 10.1136/bmj.282.6258.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tamborlane W. V., Puklin J. E., Bergman M., Verdonk C., Rudolf M. C., Felig P., Genel M., Sherwin R. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care. 1982 May-Jun;5 (Suppl 1):58–64. [PubMed] [Google Scholar]
  45. Travis L. B. "Overcontrol" of juvenile diabetes mellitus. South Med J. 1975 Jun;68(6):767–771. doi: 10.1097/00007611-197506000-00028. [DOI] [PubMed] [Google Scholar]
  46. Tunbridge W. M. Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association. Lancet. 1981 Sep 12;2(8246):569–572. doi: 10.1016/s0140-6736(81)90950-8. [DOI] [PubMed] [Google Scholar]
  47. Unger R. H. Meticulous control of diabetes: benefits, risks, and precautions. Diabetes. 1982 Jun;31(6 Pt 1):479–483. doi: 10.2337/diab.31.6.479. [DOI] [PubMed] [Google Scholar]
  48. Waal-Manning H. J. Can beta-blockers be used in diabetic patients? Drugs. 1979 Mar;17(3):157–160. doi: 10.2165/00003495-197917030-00002. [DOI] [PubMed] [Google Scholar]
  49. White N. H., Skor D. A., Cryer P. E., Levandoski L. A., Bier D. M., Santiago J. V. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983 Mar 3;308(9):485–491. doi: 10.1056/NEJM198303033080903. [DOI] [PubMed] [Google Scholar]
  50. Wilson D. E. Excessive insulin therapy: biochemical effects and clinical repercussions. Current concepts of counterregulation in type I diabetes. Ann Intern Med. 1983 Feb;98(2):219–227. doi: 10.7326/0003-4819-98-2-219. [DOI] [PubMed] [Google Scholar]
  51. Winter R. J. Profiles of metabolic control in diabetic children-frequency of asymptomatic nocturnal hypoglycemia. Metabolism. 1981 Jul;30(7):666–672. doi: 10.1016/0026-0495(81)90081-0. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES